NORTHAMPTON, MA / ACCESSWIRE / / IlluminaThe comprehensive method provides improved detection and greater insight on the ...

A Yale School of Medicine team has created lists of criteria to help clinicians determine when next-generation sequencing ...

Two of three patients achieved both complete remission and MRD-negative status High response rates observed in earlier studies continue in ongoing mipletamig trial Cohort 2 enrollment commencing ...

Novel triple-drug therapies are showing promise for patients with various kinds of leukemia, researchers reported at the American Society of Hematology meeting in San Diego.

Novel triple-drug therapies are showing promise for patients with various kinds of leukemia, researchers reported at the ...

A Bixby man whose gift of kindness caught our attention and made national headlines last Christmas has one more gift to give.

TuHURA Biosciences, Inc. (Nasdaq: HURA) is a Phase 3 registration-stage immuno-oncology company developing novel technologies ...

In a report released today, Samantha Semenkow from Citi maintained a Buy rating on Argenx Se (ARGX – Research Report), with a price target of ...

Moleculin Biotech shares are trading higher on Wednesday after the company announced the online publication of preclinical ...

The benefit of the PARP inhibitor in patients with germline BRCA pathogenic variants remains evident 10 years after the first ...

Cincinnati Bengals wide receiver Ja'Marr Chase danced a touchdown celebration against the Dallas Cowboys in honor of Texas boy's Brixton Wood cancer battle.